CUSP, together with three other friends of the court, has filed an amicus brief asking the U.S. Supreme Court to end the federal government’s prosecutions of health care providers for unintentional prescribing errors. This case is “about the millions of people who need and use controlled medicines responsibly….”
This week, the not-for-profit Center for U.S. Policy (CUSP) is urging the federal government not to pursue any claims it may have to state opioid litigation proceeds. “U.S. communities desperately need more resources to prevent and treat substance use disorders, provide compassionate care for people who use drugs, and support people in recovery.”
A bill introduced in the U.S. House of Representatives would loosen federal restrictions on access to medication for opioid use disorder. The Improving Access to Care and Treatment (IMPACT) Act would increase the amount of time prescribers may store long-acting injectable (LAI) buprenorphine dispensed from a specialty pharmacy for administration to their patients.
Where someone lives should not restrict their access to naloxone, medicine that can reverse any opioid overdose. That is why, @ONDCP and @theLAPPA released a state model law to help make access consistent across the country and save lives.
https://www.whitehouse.gov/ondcp/briefing-room/2021/11/17/white-house-releases-state-model-law-to-help-make-access-to-naloxone-consistent-across-the-country/
@USPolicyCenter @LynnRWebsterMD @MCBtweets @RonChapmanAtty Oh thank god!! We need help for #pain patients so badly!
7th grade. That's how far-reaching the #opioid crisis is. The continued tragedy of #overdose is unfathomable. https://bit.ly/32vro3k
